<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">MBio</journal-id><journal-id journal-id-type="hwp">mbio</journal-id><journal-id journal-id-type="pmc">mbio</journal-id><journal-id journal-id-type="publisher-id">mBio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6315100</article-id><article-id pub-id-type="pmid">30602580</article-id><article-id pub-id-type="publisher-id">mBio01918-18</article-id><article-id pub-id-type="doi">10.1128/mBio.01918-18</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="overline"><subject>Host-Microbe Biology</subject></subj-group><subj-group subj-group-type="editorial-class"><subject>Editor's Pick</subject></subj-group></article-categories><title-group><article-title><italic>Staphylococcus aureus</italic> Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin</article-title><alt-title alt-title-type="running-head"><italic>Staphylococcus aureus</italic> Targets Human Dendritic Cells</alt-title><alt-title alt-title-type="short-authors">Berends et al.</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Berends</surname><given-names>Evelien T. M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zheng</surname><given-names>Xuhui</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zwack</surname><given-names>Erin E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>M&#x000e9;nager</surname><given-names>Micka&#x000eb;l M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="author-notes" rid="fn1">*</xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Cammer</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Shopsin</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="no"><name><surname>Torres</surname><given-names>Victor J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label><addr-line>Department of Microbiology, New York University School of Medicine, New York, New York, USA</addr-line></aff><aff id="aff2"><label>b</label><addr-line>Molecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, New York, USA</addr-line></aff><aff id="aff3"><label>c</label><addr-line>Microscopy Laboratory, Division of Advanced Research Technologies, New York University School of Medicine, New York, New York, USA</addr-line></aff><aff id="aff4"><label>d</label><addr-line>Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, New York, USA</addr-line></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Freitag</surname><given-names>Nancy E.</given-names></name><role>Editor</role><aff>University of Illinois at Chicago</aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Victor J. Torres, <email>Victor.Torres@nyumc.org</email>.</corresp><fn id="fn1" fn-type="present-address"><label>*</label><p>Present address: Micka&#x000eb;l M. M&#x000e9;nager, INSERM UMR1163, Institut Imagine, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Paris, France.</p></fn><fn fn-type="equal"><p>E.T.M.B., X.Z., and E.E.Z. contributed equally to this article.</p></fn></author-notes><pub-date pub-type="epub"><day>2</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><season>Jan-Feb</season><year>2019</year></pub-date><volume>10</volume><issue>1</issue><elocation-id>e01918-18</elocation-id><history><date date-type="received"><day>30</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Berends et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Berends et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mbo001194235001.pdf"/><abstract abstract-type="precis"><p>Antigen-presenting cells such as dendritic cells (DCs) fulfill an indispensable role in the development of adaptive immunity by producing proinflammatory cytokines and presenting microbial antigens to lymphocytes to trigger a faster, specific, and long-lasting immune response. Here, we studied the effect of <named-content content-type="genus-species">Staphylococcus aureus</named-content> toxins on human DCs. We discovered that the leukocidin LukAB hinders the development of adaptive immunity by targeting human DCs. The ability of <named-content content-type="genus-species">S. aureus</named-content> to blunt the function of DCs could help explain the high frequency of recurrent <named-content content-type="genus-species">S. aureus</named-content> infections. Taken together, the results from this study suggest that therapeutically targeting the <named-content content-type="genus-species">S. aureus</named-content> leukocidins may boost effective innate and adaptive immune responses by protecting innate leukocytes, enabling proper antigen presentation and T cell activation.</p></abstract><abstract><title>ABSTRACT</title><p><named-content content-type="genus-species">Staphylococcus aureus</named-content> is a human pathogen responsible for high morbidity and mortality worldwide. Recurrent infections with this bacterium are common, suggesting that <named-content content-type="genus-species">S. aureus</named-content> thwarts the development of sterilizing immunity. <named-content content-type="genus-species">S. aureus</named-content> strains that cause disease in humans produce up to five different bicomponent toxins (leukocidins) that target and lyse neutrophils, innate immune cells that represent the first line of defense against <named-content content-type="genus-species">S. aureus</named-content> infections. However, little is known about the role of leukocidins in blunting adaptive immunity. Here, we explored the effects of leukocidins on human dendritic cells (DCs), antigen-presenting cells required for the development of adaptive immunity. Using an <italic>ex vivo</italic> infection model of primary human monocyte-derived dendritic cells, we found that <named-content content-type="genus-species">S. aureus</named-content>, including strains from different clonal complexes and drug resistance profiles, effectively kills DCs despite efficient phagocytosis. Although all purified leukocidins could kill DCs, infections with live bacteria revealed that <named-content content-type="genus-species">S. aureus</named-content> targets and kills DCs primarily via the activity of leukocidin LukAB. Moreover, using coculture experiments performed with DCs and autologous CD4<sup>+</sup> T lymphocytes, we found that LukAB inhibits DC-mediated activation and proliferation of primary human T cells. Taken together, the data determined in the study reveal a novel immunosuppressive strategy of <named-content content-type="genus-species">S. aureus</named-content> whereby the bacterium blunts the development of adaptive immunity via LukAB-mediated injury of DCs.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>MRSA</kwd><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>antigen-presenting cells</kwd><kwd>dendritic cells</kwd><kwd>immune system</kwd><kwd>leukocidin</kwd><kwd>pore-forming toxins</kwd><kwd>toxin</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution><institution-id>https://doi.org/10.13039/100000060</institution-id></institution-wrap></funding-source><award-id>AI099394</award-id><principal-award-recipient><name><surname>Torres</surname><given-names>Victor J.</given-names></name></principal-award-recipient></award-group><award-group id="award2"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution><institution-id>https://doi.org/10.13039/100000060</institution-id></institution-wrap></funding-source><award-id>AI105129</award-id><principal-award-recipient><name><surname>Torres</surname><given-names>Victor J.</given-names></name></principal-award-recipient></award-group></funding-group><counts><fig-count count="6"/><table-count count="1"/><equation-count count="0"/><ref-count count="71"/><page-count count="16"/><word-count count="10091"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January/February 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p><named-content content-type="genus-species">Staphylococcus aureus</named-content> is an important opportunistic Gram-positive pathogen that causes infections in humans (<xref rid="B1" ref-type="bibr">1</xref>). Around 30% of the human population is asymptomatically colonized with <named-content content-type="genus-species">S. aureus</named-content> (<xref rid="B2" ref-type="bibr">2</xref>). However, when <named-content content-type="genus-species">S. aureus</named-content> manages to become invasive, it causes a wide array of serious infections. With no vaccine currently available (<xref rid="B3" ref-type="bibr">3</xref>) and with the increasing levels of multidrug-resistant methicillin-resistant <named-content content-type="genus-species">S. aureus</named-content> (MRSA) strains (<xref rid="B4" ref-type="bibr">4</xref>), <named-content content-type="genus-species">S. aureus</named-content> infections pose a serious public health threat. MRSA has plagued the hospitals for decades and is now frequently recovered from seemingly healthy individuals owing to the emergence of community-associated MRSA (CA-MRSA). CA-MRSA infections caused by clone USA300, the predominant cause of community-acquired skin infections in the United States (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>), frequently recur, indicating that primary infection does not induce protective immunity.</p><p>A key feature of <named-content content-type="genus-species">S. aureus</named-content> that facilitates its pathogenic lifestyle is the production of a large array of virulence factors that thwart the immune system (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). An important group of these virulence factors consists of the bicomponent pore-forming leukocidins (here referred to collectively as &#x0201c;leukocidins&#x0201d;) (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). <named-content content-type="genus-species">S. aureus</named-content> clinical isolates, including USA300 (<xref rid="B11" ref-type="bibr">11</xref>), produce up to five different leukocidins: leukocidin ED (LukED), Panton-Valentine leukocidin (PVL), leukocidin AB (LukAB, also known as LukGH), and &#x003b3;-hemolysins AB and CB (HlgAB and HlgCB) (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Leukocidins consist of two subunits (denoted S and F) that oligomerize to form membrane-spanning pores that lyse target cells. These toxins target a wide array of immune cells (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>), the most extensively studied of which are the neutrophils, representing critical components of the initial immune defense against bacteria (<xref rid="B7" ref-type="bibr">7</xref>). Initial binding of the toxin occurs via recognition of leukocyte receptors, which dictate the cell specificity exhibited by these toxins (<xref rid="B10" ref-type="bibr">10</xref>). Additionally, the specific targeting of human receptors but not of the counterpart receptors in mice leads to human-specific tropism that hampers research of these toxins <italic>in vivo</italic> (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>While the activity of leukocidins against human neutrophils, monocytes, and macrophages has been well documented (<xref rid="B10" ref-type="bibr">10</xref>), the effects of these toxins on dendritic cells (DCs), which are considered the most important and efficient antigen-presenting cells within the immune system (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>), remain to be fully defined. Bridging innate immunity and adaptive immunity, DCs fulfill an indispensable role in the development of durable immune protection by producing proinflammatory cytokines and presenting microbial antigens to lymphocytes (<xref rid="B12" ref-type="bibr">12</xref>). However, the details of <named-content content-type="genus-species">S. aureus</named-content>-human DC interactions and the mechanisms employed by the bacterium to subvert these important immune cells remain incompletely defined (<xref rid="B14" ref-type="bibr">14</xref><xref ref-type="bibr" rid="B15">&#x02013;</xref><xref rid="B17" ref-type="bibr">17</xref>).</p><p>In this study, we characterized the interaction between <named-content content-type="genus-species">S. aureus</named-content> and human monocyte-derived DCs. Our data indicate that <named-content content-type="genus-species">S. aureus</named-content> targets and kills DCs, an effect mediated primarily by the LukAB leukocidin. Moreover, we demonstrate that by both directly killing and dampening levels of antigen presentation molecules on the surface of DCs, LukAB impairs DC-mediated activation of CD4<sup>+</sup> T lymphocytes. Collectively, our data suggest that targeting DCs could facilitate <named-content content-type="genus-species">S. aureus</named-content> pathogenesis by blunting the development of adaptive immunity.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2.1"><title><named-content content-type="genus-species">S. aureus</named-content> kills human DCs independently of clonal complex or drug resistance.</title><p>To study <named-content content-type="genus-species">S. aureus</named-content>-DC interactions, we generated human monocyte-derived DCs (MDDCs or DCs) and infected them with a collection of <named-content content-type="genus-species">S. aureus</named-content> isolates from different clonal complexes (CC). Our panel comprised methicillin-sensitive <named-content content-type="genus-species">S. aureus</named-content> (MSSA) and methicillin-resistant <named-content content-type="genus-species">S. aureus</named-content> (MRSA) strains, including strains associated with hospital-acquired and community-acquired infections (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). Overall, these experiments demonstrated that, in general, <named-content content-type="genus-species">S. aureus</named-content> kills DCs independently of the clonal complex, antibiotic resistance, or the type of clinical infection from which isolates were obtained (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>; see also <xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>).</p><table-wrap id="tab1" orientation="portrait" position="float"><label>TABLE&#x000a0;1</label><caption><p><italic>S. aureus</italic> isolates and strains used in study<xref ref-type="table-fn" rid="ngtab1.1"><sup><italic>a</italic></sup>
</xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Strain</th><th rowspan="1" colspan="1">Background</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Reference or source</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">VJT 12.61</td><td rowspan="1" colspan="1">USA300</td><td rowspan="1" colspan="1">WT LAC</td><td rowspan="1" colspan="1"><xref rid="B60" ref-type="bibr">60</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 20.06</td><td rowspan="1" colspan="1">USA300</td><td rowspan="1" colspan="1">WT FPR3757</td><td rowspan="1" colspan="1"><xref rid="B61" ref-type="bibr">61</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 15.36</td><td rowspan="1" colspan="1">USA300</td><td rowspan="1" colspan="1">WT BK18807</td><td rowspan="1" colspan="1"><xref rid="B25" ref-type="bibr">25</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 10.21</td><td rowspan="1" colspan="1">USA500</td><td rowspan="1" colspan="1">WT BK2395</td><td rowspan="1" colspan="1"><xref rid="B62" ref-type="bibr">62</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 1.01</td><td rowspan="1" colspan="1">Newman</td><td rowspan="1" colspan="1">WT Newman MSSA</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 15.46</td><td rowspan="1" colspan="1">ST239</td><td rowspan="1" colspan="1">WT BK23604 (BS991)</td><td rowspan="1" colspan="1">Shopsin laboratory</td></tr><tr><td rowspan="1" colspan="1">VJT 21.06</td><td rowspan="1" colspan="1">USA800</td><td rowspan="1" colspan="1">WT NRS387</td><td rowspan="1" colspan="1">NARSA (<xref rid="B25" ref-type="bibr">25</xref>)</td></tr><tr><td rowspan="1" colspan="1">VJT 5.81</td><td rowspan="1" colspan="1">CC8</td><td rowspan="1" colspan="1">WT BK4645b MSSA</td><td rowspan="1" colspan="1"><xref rid="B63" ref-type="bibr">63</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 4.79</td><td rowspan="1" colspan="1">USA400</td><td rowspan="1" colspan="1">WT MW2 CA-MRSA</td><td rowspan="1" colspan="1"><xref rid="B64" ref-type="bibr">64</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 50.06</td><td rowspan="1" colspan="1">CC1</td><td rowspan="1" colspan="1">WT MSSA476</td><td rowspan="1" colspan="1"><xref rid="B65" ref-type="bibr">65</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 50.03</td><td rowspan="1" colspan="1">CC5</td><td rowspan="1" colspan="1">WT N315 HA-MRSA</td><td rowspan="1" colspan="1"><xref rid="B66" ref-type="bibr">66</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 50.04</td><td rowspan="1" colspan="1">USA700</td><td rowspan="1" colspan="1">WT 502A</td><td rowspan="1" colspan="1"><xref rid="B67" ref-type="bibr">67</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 21.02</td><td rowspan="1" colspan="1">USA100</td><td rowspan="1" colspan="1">WT NRS382</td><td rowspan="1" colspan="1">NARSA</td></tr><tr><td rowspan="1" colspan="1">VJT 23.05</td><td rowspan="1" colspan="1">USA100</td><td rowspan="1" colspan="1">WT MSSA#16</td><td rowspan="1" colspan="1"><xref rid="B40" ref-type="bibr">40</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 35.72</td><td rowspan="1" colspan="1">USA100</td><td rowspan="1" colspan="1">WT NRS786</td><td rowspan="1" colspan="1">NARSA</td></tr><tr><td rowspan="1" colspan="1">VJT 35.74</td><td rowspan="1" colspan="1">USA100</td><td rowspan="1" colspan="1">WT NRS788</td><td rowspan="1" colspan="1">NARSA</td></tr><tr><td rowspan="1" colspan="1">VJT 38.02</td><td rowspan="1" colspan="1">USA100</td><td rowspan="1" colspan="1">WT MSSA#27</td><td rowspan="1" colspan="1"><xref rid="B40" ref-type="bibr">40</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 15.44</td><td rowspan="1" colspan="1">CC30</td><td rowspan="1" colspan="1">WT BK22820 phage-type 80/81 pandemic strain (BS992)</td><td rowspan="1" colspan="1">Shopsin laboratory</td></tr><tr><td rowspan="1" colspan="1">VJT 50.09</td><td rowspan="1" colspan="1">CC30</td><td rowspan="1" colspan="1">WT ATCC 25923</td><td rowspan="1" colspan="1">ATCC</td></tr><tr><td rowspan="1" colspan="1">VJT 2.59</td><td rowspan="1" colspan="1">USA200</td><td rowspan="1" colspan="1">WT UAMS-1</td><td rowspan="1" colspan="1"><xref rid="B68" ref-type="bibr">68</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 21.08</td><td rowspan="1" colspan="1">USA1100</td><td rowspan="1" colspan="1">WT NRS484</td><td rowspan="1" colspan="1">NARSA (<xref rid="B25" ref-type="bibr">25</xref>)</td></tr><tr><td rowspan="1" colspan="1">VJT 38.11</td><td rowspan="1" colspan="1">USA600</td><td rowspan="1" colspan="1">WT MSSA#37</td><td rowspan="1" colspan="1"><xref rid="B40" ref-type="bibr">40</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 14.26</td><td rowspan="1" colspan="1">USA300</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> LAC</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 16.39</td><td rowspan="1" colspan="1">USA300</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> BK18807</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 11.39</td><td rowspan="1" colspan="1">USA400</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> MW2</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 22.31</td><td rowspan="1" colspan="1">Newman</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> Newman</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 11.36</td><td rowspan="1" colspan="1">CC8</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> BK4645b</td><td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 15.78</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">WT (AH1263)</td><td rowspan="1" colspan="1"><xref rid="B69" ref-type="bibr">69</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 47.15</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>hlgACB</italic>::<italic>tet lukED</italic>::<italic>kan pvl</italic>::<italic>spec</italic> &#x00394;<italic>lukAB</italic> (&#x00394;&#x00394;&#x00394;&#x00394;&#x00394; USA300)</td><td rowspan="1" colspan="1"><xref rid="B70" ref-type="bibr">70</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 44.10</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>pvl</italic>::<italic>spec</italic></td><td rowspan="1" colspan="1"><xref rid="B71" ref-type="bibr">71</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 30.01</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>lukED</italic>::<italic>kan</italic></td><td rowspan="1" colspan="1"><xref rid="B71" ref-type="bibr">71</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 29.98</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>hlgACB</italic>::<italic>tet</italic></td><td rowspan="1" colspan="1"><xref rid="B70" ref-type="bibr">70</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 23.52</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic></td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 38.84</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>hlgACB</italic>::<italic>tet lukED</italic>::<italic>kan pvl</italic>::<italic>spec</italic></td><td rowspan="1" colspan="1"><xref rid="B70" ref-type="bibr">70</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 49.33</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">WT pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">VJT 49.34</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>hlgACB</italic>::<italic>tet lukED</italic>::<italic>kan pvl</italic>::<italic>spec</italic> &#x00394;<italic>lukAB</italic> pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">VJT 49.35</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">&#x00394;<italic>lukAB</italic> pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">VJT 49.36</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1"><italic>hlgACB</italic>::<italic>tet lukED</italic>::<italic>kan pvl</italic>::<italic>spec</italic> pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">VJT 26.87</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-lux, luciferase reporter promoterless control (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 26.89</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-p<italic>lukAB</italic>-lux, <italic>lukAB</italic> promoter driving expression of <italic>lux</italic> operon (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 26.91</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-p<italic>lukSF-PV-</italic>lux, <italic>pvl</italic> promoter driving expression of <italic>lux</italic> operon (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 26.92</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-p<italic>hlgCB-</italic>lux, <italic>hlgCB</italic> promoter driving expression of <italic>lux</italic> operon (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 26.93</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-p<italic>hlgA-</italic>lux, <italic>hlgA</italic> promoter driving expression of <italic>lux</italic> operon (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 26.95</td><td rowspan="1" colspan="1">USA300 LAC</td><td rowspan="1" colspan="1">pXEN1-p<italic>lukED-</italic>lux, <italic>lukED</italic> promoter driving expression of <italic>lux</italic> operon (Cm<sup>r</sup>)</td><td rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">11</xref></td></tr><tr><td rowspan="1" colspan="1">VJT 31.57</td><td rowspan="1" colspan="1">Newman</td><td rowspan="1" colspan="1">&#x00394;<italic>lukED</italic> &#x00394;<italic>hlgACB</italic>::<italic>tet</italic> &#x00394;<italic>lukAB</italic>::<italic>spec</italic> &#x00394;<italic>hla</italic>::<italic>ermC</italic> (&#x00394;&#x00394;&#x00394;&#x00394;&#x00394; Newman)</td><td rowspan="1" colspan="1"><xref rid="B59" ref-type="bibr">59</xref></td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="ngtab1.1"><label>a</label><p>WT, wild type; HA-MRSA, hospital-acquired <named-content content-type="genus-species">S. aureus</named-content>; Cm<sup>r</sup>, chloramphenicol resistance; NARSA, Network on Antimicrobial Resistance in <italic>S. aureus</italic>; ATCC, American Type Culture Collection.</p></fn></table-wrap-foot></table-wrap><fig id="fig1" orientation="portrait" position="float"><label>FIG&#x000a0;1</label><caption><p><named-content content-type="genus-species">S. aureus</named-content> targets and kills human DCs. Monocyte-derived DCs were infected with a panel of clinical isolates from different clonal complexes, including MSSA and MRSA strains. Cells were infected at an MOI of 10 for 2&#x02009;h. As a measure of cell lysis, the release of LDH was monitored (% Cell Lysis) and normalized to 100% cell lysis with 0.05% Triton X-100. Each data point represents an individual human donor; the bars indicate overall means &#x000b1; standard errors of the means (SEM); <italic>n</italic> = 5 to 8 donors.</p></caption><graphic xlink:href="mbo0061842350001"/></fig></sec><sec id="s2.2"><title>Leukocidins directly kill human DCs.</title><p>Among the virulence factors produced by <named-content content-type="genus-species">S. aureus</named-content>, the leukocidins are prime candidates for DC cytolysins as these potent toxins are known to target other human leukocytes during <named-content content-type="genus-species">S. aureus</named-content>-host cell interactions (<xref rid="B10" ref-type="bibr">10</xref>). Since all leukocidins target primary human neutrophils (also known as polymorphonuclear leukocytes [PMNs]) (<xref rid="B18" ref-type="bibr">18</xref>), we first compared the levels of susceptibility of human DCs and PMNs to purified leukocidins. As expected, all the leukocidins lysed human PMNs (<xref rid="B18" ref-type="bibr">18</xref>), albeit with different potencies (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2A</xref>). We found that all the leukocidins also killed DCs, with LukAB and PVL being the most lytic (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>).</p><fig id="fig2" orientation="portrait" position="float"><label>FIG&#x000a0;2</label><caption><p>LukAB is responsible for killing DCs during <named-content content-type="genus-species">S. aureus</named-content> infection. (A and B) Viability of primary human PMNs (A) and monocyte-derived DCs (B) after exposure to purified leukocidins was analyzed by detecting the release of LDH. Bars indicate means &#x000b1; SEM, with <italic>n</italic> = 7 donors. (C) Infection of monocyte-derived DCs for 2&#x02009;h at an MOI of 10 with a panel of isogenic mutant strains in the USA300 AH-LAC background. Each data point represents an individual human donor; the bars indicate means of percentages of cell lysis &#x000b1; SEM as measured by LDH release; <italic>n</italic> = 6 donors. (D) The presence and absence of LukAB in culture supernatants of a panel of isogenic mutants were evaluated by immunoblotting with an anti-LukA antibody (top panel). In addition, the presence of alpha-toxin (Hla) was analyzed to verify that the <italic>lukAB</italic> mutation did not interfere with the production of other <named-content content-type="genus-species">S. aureus</named-content> toxins. (E) Infection of monocyte-derived DCs for 2&#x02009;h at an MOI of 10 with isogenic wt and &#x00394;<italic>lukAB</italic> bacteria from different MSSA and MRSA backgrounds. Each data point represents an individual human donor; the bars indicate means of percentages of cell lysis &#x000b1; SEM as measured by LDH release; <italic>n</italic> = 4 donors. (F) The presence of LukAB in culture supernatants of <named-content content-type="genus-species">S. aureus</named-content> clinical isolates was evaluated by immunoblotting with an anti-LukB antibody.</p></caption><graphic xlink:href="mbo0061842350002"/></fig></sec><sec id="s2.3"><title><named-content content-type="genus-species">S. aureus</named-content> kills DCs via LukAB.</title><p>Next, we examined if the leukocidins are responsible for killing DCs during infection with live <named-content content-type="genus-species">S. aureus</named-content>. To this end, we used a panel of isogenic mutants in a representative CA-MRSA USA300 strain background (<xref rid="B19" ref-type="bibr">19</xref>). The wild-type (wt) USA300 strain potently killed DCs, whereas a mutant lacking all the leukocidins (&#x00394;<italic>hlgACB</italic> &#x00394;<italic>lukED</italic> &#x00394;<italic>pvl</italic> &#x00394;<italic>lukAB</italic> USA300 [&#x00394;&#x00394;&#x00394;&#x00394;&#x00394; USA300]) was unable to lyse those cells (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>). We next tested isogenic USA300 mutants that lacked each of the individual leukocidins. These experiments identified LukAB as the leukocidin responsible for USA300-mediated targeting and killing of DCs during infection (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>), as the deletion of <italic>lukAB</italic> mirrored the lack of cytotoxicity exhibited by the isogenic strain lacking all the toxins. Consistent with this observation, an isogenic mutant lacking all leukocidins except LukAB (mutant &#x00394;<italic>hlgACB</italic> &#x00394;<italic>lukED</italic> &#x00394;<italic>pvl</italic>) exhibited cytolytic activity similar to that shown by the wt strain (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>).</p><p>To further investigate the role of LukAB in killing DCs, we used a collection of isogenic wt or &#x00394;<italic>lukAB</italic> MRSA and MSSA strains (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>) (<xref rid="B20" ref-type="bibr">20</xref>). Western blot analyses of these strains verified the presence or absence of LukAB. All the strains produced alpha-toxin (Hla), which was used as a positive control (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2D</xref>). Infection of DCs with this diverse collection of strains further established the role of LukAB in killing human DCs (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2E</xref>). Since most of the tested clinical isolates were cytotoxic toward DCs (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>), we next analyzed the supernatants of these strains by Western blotting to correlate LukAB levels with their cytotoxic activity. As expected, LukAB was produced by all the highly cytotoxic strains whereas lower levels were detected in the supernatant of strains that were less cytotoxic toward DCs (e.g., strains N315, UAMS-1, and NRS382) (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2F</xref>).</p></sec><sec id="s2.4"><title>PMNs and DCs are equally susceptible to LukAB-mediated killing during <named-content content-type="genus-species">S. aureus</named-content> infection.</title><p>We next compared the susceptibility of both PMNs and DCs to infection with USA300 wt and &#x00394;<italic>lukAB</italic> bacteria at various multiplicities of infection (MOIs) for 2&#x02009;h (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref>) or at different time points postinfection with an MOI of 10 (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3B</xref>). These results highlight that human PMNs and DCs are similarly susceptible to USA300-mediated killing. Regardless, we observed that LukAB is the dominant toxin that mediates killing of both human phagocytes irrespective of the bacterial inoculum or infection time (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3A</xref> and <xref ref-type="fig" rid="fig3">B</xref>).</p><fig id="fig3" orientation="portrait" position="float"><label>FIG&#x000a0;3</label><caption><p>LukAB-mediated killing of DCs during <named-content content-type="genus-species">S. aureus</named-content> infection is associated with increased CD11b levels and activation of apoptosis. (A) A direct comparison of the levels of infection of PMNs and monocyte-derived DCs with isogenic wt or &#x00394;<italic>lukAB</italic> USA300 AH-LAC. Cell lysis was measured via LDH release after 2 h of infection at MOIs of 0.1, 1, 5, 10, and 25. (B) Infection of PMNs and monocyte-derived DCs with wt and &#x00394;<italic>lukAB</italic> bacteria at an MOI of 10 for 15&#x02009;min, 1, 2, and 4&#x02009;h. Values in panels A and B are plotted as means &#x000b1; SEM; <italic>n</italic> = 4 donors. (C and D) Leukocidin promoter activity was measured by luminescence of wt bacteria harboring plasmids of leukocidin promoter sequences fused to the luciferase gene in the absence or presence of PMNs (C) and monocyte-derived DCs (D). Each data point represents an individual human donor; the bars indicate means &#x000b1; SEM; <italic>n</italic> = 5-6 donors. Data were analyzed using an unpaired, two-tailed Student's <italic>t</italic> test. RLU, relative light units. (E) Semiquantitative levels of total CD11b (geometric mean fluorescence intensity [MFI]) on both PMNs and monocyte-derived DCs from the same donors were measured by flow cytometry; <italic>n</italic> = 9 donors. The results were analyzed using a paired, two-tailed Student's <italic>t</italic> test. (F) Monocyte-derived DCs were pretreated with 2% DMSO (Vehicle), 200&#x02009;&#x000b5;M necrostatin-1 (Nec-1), 100&#x02009;&#x000b5;M necrosulfonamide (NSA), 50&#x02009;&#x000b5;M GSK-872, 200&#x02009;&#x000b5;M VX-765, 200&#x02009;&#x000b5;M Ac-DEVD-CHO, or 200&#x02009;&#x000b5;M Z-VAD-FMK and were then infected with wt or &#x00394;<italic>lukAB</italic> bacteria at an MOI of 5. Cell lysis was measured via LDH release 2 h postinfection. The dotted horizontal line represents the mean percentages of cell lysis of wt-infected, vehicle-treated cells. Each data point represents an individual human donor; bars indicate means &#x000b1; SEM; <italic>n</italic> = 8 donors. <italic>P</italic> values against the vehicle control were determined using one-way analysis of variance (ANOVA) and Dunnett&#x02019;s multiple-comparison tests. Asterisks indicate statistical differences with <italic>P</italic> values as follows: *, <italic>P</italic> &#x0003c; 0.05; **, <italic>P</italic> &#x0003c; 0.01; ***, <italic>P</italic> &#x0003c; 0.001; ****, <italic>P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="mbo0061842350003"/></fig><p>Previously, it was shown that human PMNs induce the expression and production of LukAB (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>), which is associated with the dominant role of this toxin in infections using primary human PMNs (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Thus, we tested whether DCs are also susceptible to <named-content content-type="genus-species">S. aureus</named-content> infection because they induce <italic>lukAB</italic> expression. To address this, we utilized USA300 reporter strains where each individual leukocidin promoter is fused to the luciferase operon from <named-content content-type="genus-species">Photorhabdus luminescens</named-content> (<xref rid="B11" ref-type="bibr">11</xref>). Consistent with previous findings, exposure of human PMNs to USA300 induced upregulation of several leukocidin promoters, predominantly <italic>lukAB</italic> (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3C</xref>). Interestingly, we found that exposure of USA300 to DCs does not increase the activation of the leukocidin promoters. In fact, the <italic>lukAB</italic> promoter activity was slightly decreased in the presence of DCs (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3D</xref>). These results suggest that even though DCs exhibit susceptibility to USA300-mediated killing similar to that exhibited by PMNs, their susceptibility to LukAB is not due to induction of the toxin during infection of these cells.</p><p>LukAB targets CD11b for lysis of human PMNs and monocytes (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Thus, we compared the levels of CD11b on the surface of PMNs and DCs by using antibodies and flow cytometry to detect CD11b on both phagocytes. We found that DCs have over 2.5-fold the amount of surface CD11b shown by PMNs (mean fluorescence intensity [MFI], 42,285 &#x000b1; 3,189 versus 106,991 &#x000b1; 10,309) (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3E</xref>). Thus, the susceptibility of DCs to LukAB is associated with higher levels of the toxin receptor on these cells.</p></sec><sec id="s2.5"><title><named-content content-type="genus-species">S. aureus</named-content> kills DCs through activation of caspase-dependent pathways.</title><p><named-content content-type="genus-species">S. aureus</named-content> and its toxins activate a wide range of cell death pathways from apoptosis to pyroptosis and necroptosis in human neutrophils, monocytes, and macrophages (<xref rid="B25" ref-type="bibr">25</xref><xref ref-type="bibr" rid="B26">&#x02013;</xref><xref rid="B31" ref-type="bibr">31</xref>). Thus, we next set out to elucidate how LukAB induces death in DCs during <named-content content-type="genus-species">S. aureus</named-content> infection. DCs were treated with inhibitors for enzymes known to play important roles in apoptosis (Z-VAD-FMK and Ac-DEVD-CHO), pyroptosis (VX-765), and necroptosis (Nec-1, NSA, and GSK-872) for 30 min prior to infecting the DCs with either USA300 wt or &#x00394;<italic>lukAB</italic> bacteria. We observed a significant decrease in LukAB-mediated cell death when DCs were treated with the pan-caspase inhibitor Z-VAD or specific inhibitors against caspase-3 (Ac-DEVD-CHO) and against caspase-1 and caspase-4 (VX-765). In contrast, no significant decrease in cell death was observed when DCs were treated with inhibitors for RIPK1 (Nec-1), MLKL (NSA), or RIPK3 (GSK-872) (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3F</xref>). These data suggest that DCs die via caspase-mediated apoptosis and pyroptosis during <named-content content-type="genus-species">S. aureus</named-content> infection.</p></sec><sec id="s2.6"><title><named-content content-type="genus-species">S. aureus</named-content> lyses DCs independently of the level of phagocytosis.</title><p>DCs are phagocytes that engulf microbes to promote antigen presentation. Therefore, we next analyzed the interaction of DCs and <named-content content-type="genus-species">S. aureus</named-content> using time-lapse microscopy. To track bacteria, we opsonized fluorescent USA300 with complement-containing human serum to promote uptake. Upon infection of DCs, bacteria were captured and internalized within 20 min (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4A</xref> and <xref ref-type="fig" rid="fig4">B</xref>).</p><fig id="fig4" orientation="portrait" position="float"><label>FIG&#x000a0;4</label><caption><p><named-content content-type="genus-species">S. aureus</named-content> kills DCs independently of the level of phagocytosis. (A) Time-lapse imaging of opsonized, fluorescent &#x00394;<italic>hlgACB</italic> &#x00394;<italic>lukED</italic> &#x00394;<italic>pvl</italic> &#x00394;<italic>lukAB</italic> (&#x00394;&#x00394;&#x00394;&#x00394;&#x00394;) USA300 (green) taken up by monocyte-derived DCs (gray). The bar represents 10&#x02009;&#x003bc;m. (B) Spatial localization of fluorescent &#x00394;&#x00394;&#x00394;&#x00394;&#x00394; USA300 (green) taken up by monocyte-derived DCs (red). The bar indicates 5&#x02009;&#x003bc;m. (C) Uptake of isogenic GFP-expressing USA300 strains by monocyte-derived DCs. Bacteria were preincubated with media (nonopsonized) or human serum (opsonized). GFP fluorescence of the DCs was analyzed by flow cytometry. Each data point represents an individual human donor; bars indicate means &#x000b1; SEM; <italic>n</italic> = 6 donors. (D) Infection of monocyte-derived DCs with nonopsonized and opsonized USA300 at an MOI of 10 for 2&#x02009;h, after which the release of LDH release was measured. Each data point represents an individual human donor; bars indicate means &#x000b1; SEM; <italic>n</italic> = 6 donors. (E) Uptake of wt USA300 in the presence or absence of 10&#x02009;&#x003bc;g/ml cytochalasin D (CytD). Monocyte-derived DCs were treated with 40&#x02009;&#x000b5;g/ml lysostaphin to kill bacteria sticking to the outer side of the cells. Each data point represents an individual human donor; bars indicate means &#x000b1; SEM; <italic>n</italic> = 3 donors. (F) Infection of monocyte-derived DCs with USA300 in the presence or absence of 10&#x02009;&#x003bc;g/ml CytD, after which LDH release was measured. Each data point represents an individual human donor; bars represent means &#x000b1; SEM; <italic>n</italic> = 5 donors; MOI = 10.</p></caption><graphic xlink:href="mbo0061842350004"/></fig><p>We next studied the USA300-DC interaction in greater detail by flow cytometry. For these experiments, fluorescent USA300 isogenic strains were used to infect DCs in the presence or absence of complement-containing human serum. We observed that opsonization promoted bacterial uptake (10% without serum to 60% with serum) (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4C</xref>). Of note, the uptake of USA300 was independent of the presence or absence of leukocidins (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4C</xref>).</p><p>We took advantage of the altered phagocytosis observed in comparisons of opsonized and nonopsonized bacteria to determine whether <named-content content-type="genus-species">S. aureus</named-content> preferentially kills DCs from outside the cells (extracellular) or from within the cells (intracellular). These experiments revealed that while opsonization influences bacterial uptake, it did not alter the lysis of the DCs (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4D</xref>). These findings were confirmed in assays where bacterial uptake was prevented by using cytochalasin D (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4E</xref> and <xref ref-type="fig" rid="fig4">F</xref>), an agent that blocks actin polymerization and, thus, phagocytosis. Collectively, these data demonstrate that <named-content content-type="genus-species">S. aureus</named-content> is effectively taken up by DCs and that the bacteria kill these independently of the level of phagocytosis in a LukAB-dependent manner.</p></sec><sec id="s2.7"><title>LukAB blocks DC-mediated activation and proliferation of human T cells.</title><p>To determine whether LukAB-mediated targeting of DCs inhibits the initiation of adaptive immunity, we assayed the activation and proliferation of primary human CD4<sup>+</sup> T cells by DCs. First, the lytic effect of leukocidins on DCs was assessed at 24&#x02009;h after toxin exposure (in contrast to intoxication for 1&#x02009;h as performed in the experiments whose results are presented in <xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>) using significantly lower (&#x0003e;100-fold) concentrations of toxin. Consistent with data obtained using high doses of toxin, DCs suffered membrane damage after 24&#x02009;h of exposure to low doses of LukAB (&#x02265;0.006&#x02009;nM) and PVL (&#x02265;0.06&#x02009;nM) (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5A</xref>). As a control, we also exposed CD4<sup>+</sup> T cells to the leukocidins and found that those cells remained intact under these conditions (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5B</xref>).</p><fig id="fig5" orientation="portrait" position="float"><label>FIG&#x000a0;5</label><caption><p>Purified LukAB dampens DC-mediated activation of human CD4<sup>+</sup> T lymphocytes. (A and B) Viability of monocyte-derived DCs (A) and CD4<sup>+</sup> T cells (B) upon exposure to low concentrations of leukocidins over a period of 24&#x02009;h, as determined by the use of a membrane-impermeative viability dye (eFluor 450). Data are plotted as mean values &#x000b1; SEM; <italic>n</italic> = 5 donors. (C) Gating strategy to identify the CD4<sup>+</sup> T cells in the total lymphocyte population (two left plots). The right two plots indicate how cell division (CFSE) and CD4<sup>+</sup> T cell activation (CD25<sup>+</sup>) are monitored. (D and E) CD4<sup>+</sup> T cell division (% Divided CD4<sup>+</sup> cells) (D) and activation (% CD25 positive cells) (E) in the presence of a concentration gradient of different leukocidins. Data are plotted as mean values &#x000b1; SEM; <italic>n</italic> = 6 donors. no sup, no supplementation.</p></caption><graphic xlink:href="mbo0061842350005"/></fig><p>We then performed experiments in which DCs were cocultured with autologous carboxyfluorescein succinimidyl ester (CFSE)-labeled CD4<sup>+</sup> T cells and stimulated with <named-content content-type="genus-species">S. aureus</named-content> cell-free supernatant from a strain lacking all the leukocidins. Of note, <named-content content-type="genus-species">S. aureus</named-content> supernatants contain a mix of antigens as well as superantigens that trigger nonspecific T cell activation. To determine the effect of toxins on T cell activation, purified leukocidins (or control buffer) was exogenously added to the coculture and the proliferation and activation of T lymphocytes were analyzed by flow cytometry. CFSE signal was used as a measure of lymphocyte proliferation, and the upregulation of CD25 was used as a marker of lymphocyte activation (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5C</xref>). CD4<sup>+</sup> T cells were not activated in the absence of DCs or <named-content content-type="genus-species">S. aureus</named-content> supernatant, confirming that it was a DC- and <named-content content-type="genus-species">S. aureus</named-content> supernatant-dependent response (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5D</xref> and <xref ref-type="fig" rid="fig5">E</xref>). After 3&#x02009;days of coculture, &#x0223c;30% of the T cells divided (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5D</xref>), which was accompanied by &#x0223c;35% of the cells upregulating CD25 (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5E</xref>). These responses were blunted when DCs were exposed to LukAB (<xref ref-type="fig" rid="fig5">Fig.&#x000a0;5D</xref> and <xref ref-type="fig" rid="fig5">E</xref>).</p></sec><sec id="s2.8"><title><named-content content-type="genus-species">S. aureus</named-content> blunts the activation of CD4<sup>+</sup> T lymphocytes by targeting DCs via LukAB.</title><p>We next wanted to determine if infection of DCs by <named-content content-type="genus-species">S. aureus</named-content> impaired the activation of CD4<sup>+</sup> T cells. DCs were infected with opsonized wt or &#x00394;<italic>lukAB</italic> USA300 cells for 3&#x02009;h. Afterward, the extracellular bacteria were killed with gentamicin overnight. The following day, CFSE-labeled autologous CD4<sup>+</sup> T cells were added to the DCs and cocultured for 3 additional days. The activation and proliferation of lymphocytes was determined as described for <xref ref-type="fig" rid="fig5">Fig.&#x000a0;5C</xref>. First, we characterized the state of DCs at 30 min, 3 h, and overnight postinfection in regard to membrane damage and surface levels of proteins involved in migration/phagocytosis (CD11c), antigen presentation (CD1c and HLA-DR), and costimulation of T cells (CD83 and CD86) (<xref rid="B32" ref-type="bibr">32</xref><xref ref-type="bibr" rid="B33">&#x02013;</xref><xref rid="B37" ref-type="bibr">37</xref>). In addition to the clear results seen with the live and dead cell populations after infection with <named-content content-type="genus-species">S. aureus</named-content> (i.e., negligible and maximum staining, respectively), we observed a third population that exhibited an intermediate level of membrane damage staining (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6A</xref>). During wt infection, the population level of the cells with negligible membrane damage began to decrease significantly in comparison to the &#x00394;<italic>lukAB</italic>-infected population and continued to be significantly lower than the &#x00394;<italic>lukAB</italic>-infected population level after overnight treatment with gentamicin (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6B</xref>). At the same time points, we observed an increase in the population of cells exhibiting intermediate staining for membrane damage during wt infection compared to &#x00394;<italic>lukAB</italic> infection (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6B</xref>). In addition to increased cell death, flow cytometry analyses of cells in the gates corresponding to low and intermediate staining revealed a decrease in the levels of CD11c and the antigen-presenting molecules CD1c and HLA-DR as well as in the levels of the costimulatory CD83 and CD86 molecules on the surface of DCs after infection with wt bacteria compared to &#x00394;<italic>lukAB</italic> bacteria (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6C</xref>).</p><fig id="fig6" orientation="portrait" position="float"><label>FIG&#x000a0;6</label><caption><p><named-content content-type="genus-species">S. aureus</named-content> inhibits DC-meadiated activation of human CD4<sup>+</sup> T lymphocytes via LukAB. (A) Gating strategy to define membrane damage in DCs upon infection with wt or &#x00394;<italic>lukAB</italic> USA300 at an MOI of 5. Membrane damage was measured by the incorporation of Zombie Red viability dye. From left to right, the three gates indicate low-level/negligible, intermediate-level, and high-level membrane damage. The percentage of DCs in each gate from a representative donor after overnight infection is shown. FSC, forward scatter. (B) Quantification of the percentages of cells in low-level and intermediate-level membrane damage gates at 30&#x02009;min postinfection, 3&#x02009;h postinfection, and after one night (overnight [o/n]) with wt or &#x00394;<italic>lukAB</italic> USA300 for all donors. (C) Geometric mean fluorescence intensity (MFI) levels were measured for CD11c, CD1c, HLA-DR, CD83, and CD86 on the surface of DCs infected with wt or &#x00394;<italic>lukAB</italic> USA300 by flow cytometry. In panels B and C, each data point represents an individual human donor, bars are plotted as mean values &#x000b1; SEM; <italic>n</italic> = 7 donors. The results were analyzed using a paired, two-tailed Student's <italic>t</italic> test. (D and E) CD4<sup>+</sup> T cell proliferation (% Divided CD4<sup>+</sup> cells) (D) and activation (% CD25 positive cells) (E) after incubation with DCs that were left unexposed (no bacteria) or infected with wt or &#x00394;<italic>lukAB</italic> USA300 at an MOI of 5. CD4<sup>+</sup> T cell proliferation and activation levels were measured 3&#x02009;days postcoculturing with DCs. Each data point represents an individual human donor, bars are plotted as mean values &#x000b1; SEM; <italic>n</italic> = 6 donors. Data were analyzed for statistical differences using a one-way ANOVA adjusted for multiple comparisons (Sidak). Asterisks indicate <italic>P</italic> values representing statistical differences as follows: *, <italic>P</italic> &#x0003c; 0.05; **, <italic>P</italic> &#x0003c; 0.01; ***, <italic>P</italic> &#x0003c; 0.001; ****, <italic>P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="mbo0061842350006"/></fig><p>Consistent with the effects of LukAB on DC viability and surface levels of antigen-presenting and costimulatory proteins, CD4<sup>+</sup> T cell and DC coculture experiments revealed that the DCs infected with wt USA300 exhibited a LukAB-dependent dampening of CD4<sup>+</sup> T cell stimulation as assayed by cell division (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6D</xref>) and CD25 upregulation (<xref ref-type="fig" rid="fig6">Fig.&#x000a0;6E</xref>).</p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p><named-content content-type="genus-species">S. aureus</named-content> commonly causes recurrent infections in the human host without the development of sterilizing immunity (<xref rid="B8" ref-type="bibr">8</xref>), suggesting that this bacterium is able to thwart the host immune response. Among the different immune cells involved in the host response to infection, DCs form the bridge between the innate and adaptive immune responses and are crucial for the effective development of immunological memory. Therefore, a comprehensive understanding of the human DC-<named-content content-type="genus-species">S. aureus</named-content> interaction and of the mechanisms that <named-content content-type="genus-species">S. aureus</named-content> employs to subvert DCs is required. Here we demonstrated that <named-content content-type="genus-species">S. aureus</named-content> (both MSSA and MRSA) targets human DCs through the activity of LukAB toxin, resulting in an impaired T cell response.</p><p>Most adults harbor <named-content content-type="genus-species">S. aureus</named-content>-specific antibodies (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Evaluation of children with invasive <named-content content-type="genus-species">S. aureus</named-content> infection revealed that production of LukAB-specific antibodies was enhanced by infection, underlining both the activation of adaptive immunity and the production of this leukocidin during infection (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Nonetheless, prior exposure to <named-content content-type="genus-species">S. aureus</named-content> does not result in sterilizing immunity or complete protection as evidenced by the frequency of recurrent infections in humans (<xref rid="B8" ref-type="bibr">8</xref>). Human <named-content content-type="genus-species">S. aureus</named-content>-specific T lymphocyte responses have been detected (<xref rid="B42" ref-type="bibr">42</xref><xref ref-type="bibr" rid="B43">&#x02013;</xref><xref rid="B45" ref-type="bibr">45</xref>), and T lymphocyte deficiencies are associated with increased susceptibility to <named-content content-type="genus-species">S. aureus</named-content> infections (<xref rid="B46" ref-type="bibr">46</xref>). Taking the data together, those studies suggested that adaptive immunity provides some but not sufficient protection against <named-content content-type="genus-species">S. aureus</named-content> reinfection. Our results suggest that by killing DCs and/or dampening the activity of critical surface molecules involved in antigen presentation and costimulation via LukAB, <named-content content-type="genus-species">S. aureus</named-content> is likely to impair the development of immunological memory or recall responses against <named-content content-type="genus-species">S. aureus</named-content>, which ultimately could result in incomplete protection against infection.</p><p>While DCs exhibit poor direct antimicrobial activity against <named-content content-type="genus-species">S. aureus</named-content> compared to neutrophils and macrophages (<xref rid="B47" ref-type="bibr">47</xref>), these cells can influence immune responses by promoting effector functions of other phagocytes (<xref rid="B48" ref-type="bibr">48</xref>). Moreover, these sentinel cells can contribute to protection against <named-content content-type="genus-species">S. aureus</named-content> by activating innate immune mechanisms (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>), resulting in &#x0201c;innate memory responses&#x0201d; (<xref rid="B51" ref-type="bibr">51</xref>). Thus, by targeting DCs, LukAB can also hinder additional aspects of the human immune response against <named-content content-type="genus-species">S. aureus</named-content>.</p><p>While the data presented here clearly demonstrate the importance of LukAB in inhibiting the functionality of and killing human DCs, the nature of the contribution of this toxin to the subversion of the development of adaptive immunity during <italic>in vivo</italic> infection remains to be defined. Although murine models have provided extremely valuable information about anti-<named-content content-type="genus-species">S. aureus</named-content> immune responses, including the involvement of DCs (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>), the species specificity exhibited by LukAB and many of the other virulence factors produced by <named-content content-type="genus-species">S. aureus</named-content> limits the utility of these models to unravel the role of these virulence factors during infection (<xref rid="B54" ref-type="bibr">54</xref>). Before <italic>in vivo</italic> experiments can be performed, fully susceptible models of infection need to be generated so that the activities of all the relevant leukocidins can be evaluated. This could be achieved by humanizing the relevant toxin receptors (<xref rid="B10" ref-type="bibr">10</xref>) or by studying humanized mice (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>).</p><p>Taking the data together, this report has advanced our understanding of how <named-content content-type="genus-species">S. aureus</named-content> subverts the human immune response to promote infection. Specifically, we identified LukAB as a potent toxin that targets and injures human DCs, highlighting a previously unknown immunosuppressive strategy employed by this pathogen. Ultimately, this knowledge could provide insight into strategies for the development of effective treatments and vaccines against <named-content content-type="genus-species">S. aureus</named-content> infection.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4.1"><title>Cell isolation and generation of DCs.</title><p>Primary human polymorphonuclear leukocytes (PMNs) and peripheral blood mononuclear cells (PBMCs) from anonymous, healthy donors (New York Blood Center) were isolated from buffy coats as previously described (<xref rid="B18" ref-type="bibr">18</xref>). PBMCs were suspended in RPMI 1640 medium (Corning) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gemini Bio-Products) and 10&#x02009;mM HEPES (Corning). To generate monocyte-derived dendritic cells, monocytes were purified from total PBMCs by plastic adherence in a 40-ml volume at a concentration of 7&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/ml in 150-cm<sup>2</sup> tissue culture flasks (Corning). After collection of the nonadherent fraction and washing of the adherent cells with RPMI medium, cells were cultured for 4&#x02009;days at 37&#x000b0;C and 5% CO<sub>2</sub> in RPMI medium supplemented with 10% FBS, 10&#x02009;mM HEPES, 100&#x02009;U/ml penicillin, 100&#x02009;&#x003bc;g/ml streptomycin, 110&#x02009;U/ml granulocyte-macrophage colony-stimulating factor (GM-CSF) (Leukine; Sanofi), and 282&#x02009;U/ml interleukin-4 (IL-4) (Affymetrix, eBioscience). The medium was replenished with fresh IL-4 and GM-CSF every 2&#x02009;days. The nonadherent monocyte-depleted PBMCs were frozen in 10% dimethyl sulfoxide (DMSO)&#x02013;40% FBS&#x02013;RPMI medium until use in T cell proliferation assays.</p></sec><sec id="s4.2"><title>Bacterial strains and culture conditions.</title><p>The <named-content content-type="genus-species">S. aureus</named-content> isolates used in this study are listed in <xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>. <named-content content-type="genus-species">S. aureus</named-content> USA300 strain AH-LAC (<xref rid="B19" ref-type="bibr">19</xref>) was used in all experiments as the wild-type (wt) strain unless otherwise indicated. Bacteria were routinely grown at 37&#x000b0;C on tryptic soy agar (TSA). Overnight cultures were grown in 5&#x02009;ml tryptic soy broth (TSB) in 15-ml tubes under shaking conditions at 180&#x02009;rpm with a 45&#x000b0; angle. A 1:100 dilution of overnight culture was subcultured into RPMI medium (Invitrogen) supplemented with 1% Casamino Acids (RPMI medium&#x02013;Cas; pH 7.3) and incubated for another 4.5&#x02009;h before being used for infection. When appropriate, chloramphenicol was supplemented to the media at a final concentration of 10&#x02009;&#x000b5;g/ml. The pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP plasmid (<xref rid="B57" ref-type="bibr">57</xref>) was transformed to the panel of AH-LAC isogenic mutant strains.</p></sec><sec id="s4.3"><title>Exoprotein isolation and immunoblotting.</title><p><named-content content-type="genus-species">S. aureus</named-content> was cultured as described above and normalized to the same optical density at 600 nm (OD<sub>600</sub>). Bacterial cells were pelleted by centrifugation at 4,000&#x02009;rpm for 10&#x02009;min. Proteins in the supernatants were filtered through a 0.2-&#x000b5;m-pore-size filter and precipitated with 10% (vol/vol) trichloroacetic acid (TCA) at 4&#x000b0;C. The precipitated proteins were washed with 100% ethanol, air-dried, resuspended with 8&#x02009;M urea and 2&#x000d7;&#x02009;SDS loading buffer, and boiled. Proteins were separated on 12% SDS-PAGE gels, transferred to nitrocellulose membranes, and probed sequentially with rabbit anti-LukA (<xref rid="B20" ref-type="bibr">20</xref>) (1:5,000), rabbit anti-LukB (<xref rid="B20" ref-type="bibr">20</xref>) (1:1,000), and rabbit anti-Hla (Sigma) (1:5,000) polyclonal antibodies. Alexa Fluor 680-conjugated goat anti-rabbit IgG (Life Technologies) (1:25,000) was used as a secondary antibody in a mixture with phosphate-buffered saline (PBS; Corning) supplemented with 0.1% Tween 20. Membranes were scanned using an Odyssey Clx imaging system (Li-Cor Biosciences).</p></sec><sec id="s4.4"><title>Infection assays.</title><p>DCs were seeded in 96-well round-bottom plates at 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells per well in a final volume of 100&#x02009;&#x000b5;l of RPMI medium without phenol red (Gibco) that was supplemented with 0.05% human serum albumin (Seracare) and 10&#x02009;mM HEPES. DCs were infected with <named-content content-type="genus-species">S. aureus</named-content> at a multiplicity of infection (MOI) of 25, 10, 5, 1, or 0.1 and incubated at 37&#x000b0;C under shaking conditions at 180&#x02009;rpm for 15&#x02009;min, 1&#x02009;h, 2&#x02009;h, or 4&#x02009;h. To assess the cell death pathways, DCs were incubated with one of the inhibitors necrostatin-1 (Nec-1; Enzo Life Sciences), necrosulfonamide (NSA; Calbiochem), GSK-872 (Calbiochem), VX-765 (Calbiochem), Ac-DEVD-CHO (Enzo Life Sciences), or Z-VAD-FMK (Selleck Chemicals) for 30&#x02009;min at 37&#x002da;C and 5% CO<sub>2</sub> without shaking prior to infection with <named-content content-type="genus-species">S. aureus</named-content>. Following infection, cells were pelleted by centrifugation at 1,500&#x02009;rpm at 4&#x000b0;C for 5&#x02009;min and lactate dehydrogenase (LDH) release was measured using the CytoTox-ONE homogeneous membrane integrity assay (Promega). In brief, 25&#x02009;&#x000b5;l of culture supernatant was mixed with 25&#x02009;&#x000b5;l of LDH reagent and incubated for 15&#x02009;min at room temperature (RT). Fluorescence was measured using a PerkinElmer 2103 Envision multilabel plate reader (excitation, 555&#x02009;nm; emission, 590&#x02009;nm) and normalized to wells containing cells without <named-content content-type="genus-species">S. aureus</named-content> (0% cell lysis) and cells with 0.05% Triton X-100 (100% cell lysis).</p></sec><sec id="s4.5"><title>Cytotoxicity assays.</title><p>To analyze the susceptibility of human PMNs and DCs to <named-content content-type="genus-species">S. aureus</named-content> leukocidins, cells were seeded at 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells per well in RPMI medium without phenol red (Gibco) supplemented with 10% FBS and incubated with recombinant <named-content content-type="genus-species">S. aureus</named-content> leukocidins for 1&#x02009;h at 37&#x000b0;C&#x02009;and&#x02009;5% CO<sub>2</sub>. After incubation, the supernatants were analyzed for the presence of LDH using the CytoTox-ONE homogeneous membrane integrity assay as described above. To determine the membrane damage of DCs and CD4<sup>+</sup> T cells after 24&#x02009;h exposure to leukocidins, cells were stained with eFluor 450 fixable viability dye (eBiosciences) and analyzed by flow cytometry (Cytoflex; Beckman Coulter).</p></sec><sec id="s4.6"><title>Luminescence reporter assays.</title><p>To measure leukocidin promoter activity in <named-content content-type="genus-species">S. aureus</named-content> during DC interactions, bacteria containing reporter plasmids (individual leukocidin promoters fused to the luciferase operon from <named-content content-type="genus-species">Photorhabdus luminescens</named-content> present in the pXEN plasmid [Xenogen]) (<xref rid="B11" ref-type="bibr">11</xref>) were used. For each experiment, bacteria were freshly streaked onto TSA plates supplemented with 10&#x02009;&#x003bc;g/ml chloramphenicol and bacteria were grown overnight in 5&#x02009;ml tryptic soy broth (TSB; BD Difco) supplemented with 10&#x02009;&#x003bc;g/ml chloramphenicol at 37&#x000b0;C under shaking conditions (180&#x02009;rpm). The following day, bacteria were first subcultured 1:100 in fresh RPMI medium&#x02013;Cas for 3&#x02009;h and subsequently subcultured 1:10 for another 3&#x02009;h in fresh RPMI medium&#x02013;Cas to reduce background luminescence. Cells and bacteria were coincubated at an MOI of 10 at 37&#x000b0;C under shaking conditions at 180&#x02009;rpm. Luminescence readings were taken at time points from time point zero to 4&#x02009;h using a PerkinElmer Envision 2103 multilabel reader. Values corresponding to the background fluorescence of medium alone were subtracted from the readings determined for the samples.</p></sec><sec id="s4.7"><title>CD11b detection.</title><p>PMNs and DCs were stained with anti-CD11b(activated)-APC monoclonal antibody (MAb) CBRM1/5 and anti-CD11b (total)-brilliant violet 605 MAb M1/70 (BioLegend). After washing, samples were fixed with PBS supplemented with 2% FBS, 2% paraformaldehyde, and 0.05% sodium azide and analyzed by flow cytometry (Cytoflex; Beckman Coulter). Data were analyzed using FlowJo software.</p></sec><sec id="s4.8"><title>Bacterium internalization assays.</title><p><named-content content-type="genus-species">S. aureus</named-content> containing the pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP plasmid was opsonized by incubation with 10% freshly isolated human serum, prepared as previously described (<xref rid="B58" ref-type="bibr">58</xref>), for 30 min at 37&#x000b0;C under shaking conditions. Nonopsonized bacteria were treated similarly but were incubated in media instead of human serum. After incubation, bacteria were washed twice, suspended in RPMI medium&#x02013;0.05% HSA&#x02013;10&#x02009;mM HEPES, and diluted to infect DCs at an MOI of 10. To prevent bacterial uptake, cytochalasin D was used during infection at a final concentration of 10&#x02009;&#x003bc;g/ml. To measure bacterial uptake, DCs and bacteria were incubated for 15&#x02009;min at 37&#x000b0;C under shaking conditions, after which samples were fixed using PBS supplemented with 2% FBS, 2% paraformaldehyde, and 0.05% sodium azide. Bacterial uptake was assessed by flow cytometry analysis, determining the green fluorescent protein (GFP) levels of the DCs. In parallel, DC lysis was assessed by measuring the release of LDH (as described above) after incubation of DCs and bacteria for 2&#x02009;h at 37&#x000b0;C under shaking conditions.</p></sec><sec id="s4.9"><title>Microscopy.</title><p>To image the uptake of bacteria by DCs, the leukocidin-lacking <named-content content-type="genus-species">S. aureus</named-content> mutant (&#x00394;<italic>hlgACB</italic> &#x00394;<italic>lukED</italic> &#x00394;<italic>pvl</italic> &#x00394;<italic>lukAB</italic>) was transformed with the pOS1-<italic>P<sub>sarA</sub></italic>-<italic>SOD</italic>-<italic>RBS</italic>-sGFP plasmid (VJT 49.34). These bacteria were subcultured for 4.5&#x02009;h in TSB&#x02013;10&#x02009;&#x003bc;g/ml chloramphenicol and subsequently opsonized in fresh human serum as described above (see &#x0201c;Bacterium internalization assays&#x0201d;). For time-lapse microscopy, 200&#x02009;&#x003bc;l of 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup>/ml DCs were seeded in RPMI medium&#x02013;0.05% HSA&#x02013;10&#x02009;mM HEPES in chambered coverglasses (Nunc; 8-well Lab-Tek chambered coverglass, catalog no. 155411) and kept at 37&#x000b0;C&#x02009;and&#x02009;5% CO<sub>2</sub> until microscopy analysis (&#x0223c;3&#x02009;h). At the microscope (Nikon Eclipse Ti; 60&#x000d7; numerical aperture [NA], 1.4 phase lens, Andor Zyla camera), a 50-&#x003bc;l volume of the preopsonized bacteria was added at 5&#x02009;&#x000d7;&#x02009;10<sup>6</sup> CFU/ml (MOI of 10) to the cells and imaged using phase contrast to delineate DCs and fluorescence to record GFP-expressing bacteria. To verify that the bacteria were completely internalized (rather than sticking to the exterior of the DCs), fixed and labeled samples were imaged using a VT-iSIM instant structured illumination microscope (VisiTech International; Leica 63&#x000d7; NA, 1.4 lens), which behaves similarly to a spinning disk confocal microscope, to collect diffraction-limited optical sections through the DCs. For this analysis, 25&#x02009;&#x003bc;l of 5&#x02009;&#x000d7;&#x02009;10<sup>7</sup>/ml bacteria was incubated with 25&#x02009;&#x003bc;l of DCs (5&#x02009;&#x000d7;&#x02009;10<sup>6</sup>/ml) and 50&#x02009;&#x003bc;l of 2% fresh human serum in a round-bottom 96-well plate for 15 min at 37&#x000b0;C under shaking conditions. After incubation, samples were fixed with 2% paraformaldehyde overnight at 4&#x000b0;C. The following day, samples were washed with Hanks&#x02019; balanced salt solution (HBSS; Corning) and incubated with 5&#x02009;&#x003bc;g/ml wheat germ agglutinin-Alexa Fluor 594 (WGA-AF594; Thermo Fisher Scientific) for 15&#x02009;min at room temperature (RT) in HBSS to stain the DCs. The samples were washed in HBSS and seeded in a chambered coverglass (&#x0223c; 2.5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> DCs/well) for microscopy analysis.</p></sec><sec id="s4.10"><title>DC-CD4<sup>+</sup> T lymphocyte coculture assays.</title><p>Autologous CD4<sup>+</sup> T lymphocytes were purified from the monocyte-depleted fraction using an EasySep human CD4<sup>+</sup> T cell enrichment kit (Stem Cell Technologies) according to manufacturer&#x02019;s instructions. Cells were typically &#x0003e;97% CD3<sup>+</sup> CD4<sup>+</sup> as determined by flow cytometry using anti-CD3-PE (phycoerythrin) Cy7 MAb UCHT1 and anti-CD4-Pacific Blue MAb OKT4 (BioLegend). CD4<sup>+</sup> T cells were then labeled with CFSE (CFSE cell division tracker kit; BioLegend) according to the manufacturer&#x02019;s instructions. In short, 10&#x02009;&#x000d7;&#x02009;10<sup>6</sup> to 100&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/ml were incubated at a concentration of 5&#x02009;&#x003bc;M CFSE in PBS for 10&#x02009;min in the dark at 37&#x000b0;C&#x02009;and&#x02009;5% CO<sub>2</sub>, after which the staining was quenched by washing the cells twice in ice-cold RPMI medium&#x02013;10% FBS. CD4<sup>+</sup> T cells and autologous DCs were plated in a TC-treated 96-well round-bottom plate at a 10:1 ratio with 50,000 CD4<sup>+</sup> T cells and a total volume of 100&#x02009;&#x003bc;l per well. Samples were plated in duplicate and were pooled on the day of analysis. For experiments using bacterial supernatant as a stimulus, a 0.01% concentration of supernatant from <named-content content-type="genus-species">S. aureus</named-content> strain Newman, which lacks all the leukocidins and alpha-toxin (&#x00394;&#x00394;&#x00394;&#x00394;&#x00394; Newman; &#x00394;<italic>lukED</italic> &#x00394;<italic>hlgACB::tet</italic> &#x00394;<italic>lukAB::spec</italic> &#x00394;<italic>hla::ermC</italic>) and naturally lacks PVL (<xref rid="B59" ref-type="bibr">59</xref>), and purified leukocidins were added to the wells. After 3&#x02009;days of coculture, samples were stained with anti-CD3-PECy7 MAb UCHT1, anti-CD4-Pacific Blue MAb OKT4, and anti-CD25-APC MAb BC96 (BioLegend). Samples were fixed by using PBS&#x02013;2% FBS&#x02013;2% paraformaldehyde&#x02013;0.05% sodium azide. The CD4<sup>+</sup> T lymphocytes were analyzed by flow cytometry for CFSE dilution and the presence of CD25.</p><p>In the assays where the DCs were infected with <named-content content-type="genus-species">S. aureus</named-content>, the DCs were preinfected statically with opsonized <named-content content-type="genus-species">S. aureus</named-content> at an MOI of 5 at 37&#x002da;C and 5% CO<sub>2</sub>. After 3&#x02009;h of infection, the cells were treated with 50&#x02009;&#x003bc;g/ml gentamicin and 1&#x000d7; penicillin-streptomycin (Corning catalog no. 30-002-CI) to kill extracellular bacteria and incubated overnight at 37&#x000b0;C&#x02009;and&#x02009;5% CO<sub>2</sub>. The next day, autologous CD4<sup>+</sup> T lymphocytes were isolated, labeled with CFSE, added to the preinfected DCs, and cocultured for 3&#x02009;days. Flow cytometry analysis was performed using a Cytoflex (Beckman Coulter), and data were analyzed using FlowJo software.</p></sec><sec id="s4.11"><title>Measurement of infection effects on DCs.</title><p>To determine the state of DCs before coculturing with T cells was performed, DCs were infected with <named-content content-type="genus-species">S. aureus</named-content> for 30&#x02009;min or 3&#x02009;h or overnight as described for the DC-CD4<sup>+</sup> T lymphocyte coculture assays. At each time point, DCs were washed, treated with Fc receptor blocking solution (human TruStain FcX; BioLegend), and then stained with anti-human CD11c-PerCP (peridinin chlorophyll protein) MAb Bu15, anti-human CD1c-Pacific Blue MAb L161, anti-human HLA-DR-APC/Cy7 MAb L243, anti-human CD83-PE MAb HB15e, and anti-human CD86-APC MAb IT2.2 or corresponding isotype controls (BioLegend). After washing, DCs were stained with Zombie Red fixable viability dye (BioLegend) to determine the level of membrane damage. The samples were fixed with PBS supplemented with 2% FBS, 2% paraformaldehyde, and 0.05% sodium azide and analyzed by flow cytometry (Cytoflex; Beckman Coulter). Data were analyzed using FlowJo software.</p></sec></sec></body><back><fn-group><fn fn-type="other"><p><bold>Citation</bold> Berends ETM, Zheng X, Zwack EE, M&#x000e9;nager MM, Cammer M, Shopsin B, Torres VJ. 2019. <italic>Staphylococcus aureus</italic> impairs the function of and kills human dendritic cells via the LukAB toxin. mBio 10:e01918-18. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.01918-18">https://doi.org/10.1128/mBio.01918-18</ext-link>.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>We are grateful to the members of the Torres laboratory for helpful discussions and for commenting on the manuscript. We also thank Thomas D. Norton, Henning Hofmann, and Nathaniel Landau for technical assistance with DC differentiation, Lina Kozhaya and Derya Unutmaz for technical assistance with the labeling and for monitoring T lymphocyte activation and proliferation, and Dan R. Littman for providing reagents.</p><p>Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH-NIAID) under award no. R01AI099394 and R01AI105129 to V.J.T. E.T.M.B. was supported by a Rubicon fellowship from the Netherlands Organisation for Scientific Research. V.J.T. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases. V.J.T. is an inventor on patents and patent applications filed by New York University School of Medicine which are currently under commercial license to Janssen Biotech Inc.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowy</surname><given-names>FD</given-names></name></person-group>
<year>1998</year>
<article-title><italic>Staphylococcus aureus</italic> infections</article-title>. <source>N Engl J Med</source>
<volume>339</volume>:<fpage>520</fpage>&#x02013;<lpage>532</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM199808203390806</pub-id>.<pub-id pub-id-type="pmid">9709046</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Missiakas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name></person-group>
<year>2016</year>
<article-title><italic>Staphylococcus aureus</italic> vaccines: deviating from the carol</article-title>. <source>J Exp Med</source>
<volume>213</volume>:<fpage>1645</fpage>&#x02013;<lpage>1653</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20160569</pub-id>.<pub-id pub-id-type="pmid">27526714</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>KU</given-names></name>, <name name-style="western"><surname>Girgenti</surname><given-names>DQ</given-names></name>, <name name-style="western"><surname>Scully</surname><given-names>IL</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>AS</given-names></name></person-group>
<year>2013</year>
<article-title>Vaccine review: &#x0201c;Staphyloccocus aureus vaccines: problems and prospects&#x0201d;</article-title>. <source>Vaccine</source>
<volume>31</volume>:<fpage>2723</fpage>&#x02013;<lpage>2730</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.04.002</pub-id>.<pub-id pub-id-type="pmid">23624095</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Deleo</surname><given-names>FR</given-names></name></person-group>
<year>2009</year>
<article-title>Waves of resistance: <italic>Staphylococcus aureus</italic> in the antibiotic era</article-title>. <source>Nat Rev Microbiol</source>
<volume>7</volume>:<fpage>629</fpage>&#x02013;<lpage>641</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro2200</pub-id>.<pub-id pub-id-type="pmid">19680247</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deleo</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Otto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kreiswirth</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Chambers</surname><given-names>HF</given-names></name></person-group>
<year>2010</year>
<article-title>Community-associated meticillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Lancet</source>
<volume>375</volume>:<fpage>1557</fpage>&#x02013;<lpage>1568</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(09)61999-1</pub-id>.<pub-id pub-id-type="pmid">20206987</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Krishnadasan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gorwitz</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Fosheim</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>McDougal</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Carey</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Talan</surname><given-names>DA</given-names></name></person-group>
<year>2006</year>
<article-title>Methicillin-resistant S. aureus infections among patients in the emergency department</article-title>. <source>N Engl J Med</source>
<volume>355</volume>:<fpage>666</fpage>&#x02013;<lpage>674</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa055356</pub-id>.<pub-id pub-id-type="pmid">16914702</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spaan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Surewaard</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Nijland</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JA</given-names></name></person-group>
<day>3</day>
<month>7</month>
<year>2013</year>
<article-title>Neutrophils versus <italic>Staphylococcus aureus</italic>: a biological tug of war</article-title>. <source>Annu Rev Microbiol</source> doi:<pub-id pub-id-type="doi">10.1146/annurev-micro-092412-155746</pub-id>.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thammavongsa</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Missiakas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name></person-group>
<year>2015</year>
<article-title>Staphylococcal manipulation of host immune responses</article-title>. <source>Nat Rev Microbiol</source>
<volume>13</volume>:<fpage>529</fpage>&#x02013;<lpage>543</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3521</pub-id>.<pub-id pub-id-type="pmid">26272408</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2014</year>
<article-title>The bicomponent pore-forming leucocidins of <italic>Staphylococcus aureus</italic></article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>78</volume>:<fpage>199</fpage>&#x02013;<lpage>230</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.00055-13</pub-id>.<pub-id pub-id-type="pmid">24847020</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spaan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JAG</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2017</year>
<article-title>Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors</article-title>. <source>Nat Rev Microbiol</source> doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2017.27</pub-id>.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuMont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Yoong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Surewaard</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Nijland</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Staphylococcus aureus</italic> elaborates leukocidin AB to mediate escape from within human neutrophils</article-title>. <source>Infect Immun</source>
<volume>81</volume>:<fpage>1830</fpage>&#x02013;<lpage>1841</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.00095-13</pub-id>.<pub-id pub-id-type="pmid">23509138</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>
<year>2015</year>
<article-title>Control of adaptive immunity by the innate immune system</article-title>. <source>Nat Immunol</source>
<volume>16</volume>:<fpage>343</fpage>&#x02013;<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni.3123</pub-id>.<pub-id pub-id-type="pmid">25789684</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Unutmaz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sano</surname><given-names>G</given-names></name>, <name name-style="western"><surname>De los Santos</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sparwasser</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vuthoori</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>RA</given-names></name></person-group>
<year>2002</year>
<article-title>In vivo depletion of CD11c<sup>+</sup> dendritic cells abrogates priming of CD8<sup>+</sup> T cells by exogenous cell-associated antigens</article-title>. <source>Immunity</source>
<volume>17</volume>:<fpage>211</fpage>&#x02013;<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1074-7613(02)00365-5</pub-id>.<pub-id pub-id-type="pmid">12196292</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parcina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Miranda-Garcia</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Durlanik</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ziegler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Over</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Georg</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Foermer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ammann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hilmi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>K-J</given-names></name>, <name name-style="western"><surname>Schiller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heeg</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schneider-Brachert</surname><given-names>W</given-names></name>, <name name-style="western"><surname>G&#x000f6;tz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bekeredjian-Ding</surname><given-names>I</given-names></name></person-group>
<year>2013</year>
<article-title>Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to <italic>Staphylococcus aureus</italic></article-title>. <source>J Immunol</source>
<volume>190</volume>:<fpage>1591</fpage>&#x02013;<lpage>1602</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1201222</pub-id>.<pub-id pub-id-type="pmid">23325892</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>SH</given-names></name></person-group>
<year>2017</year>
<article-title>Wall teichoic acid is an essential component of <italic>Staphylococcus aureus</italic> for the induction of human dendritic cell maturation</article-title>. <source>Mol Immunol</source>
<volume>81</volume>:<fpage>135</fpage>&#x02013;<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molimm.2016.12.008</pub-id>.<pub-id pub-id-type="pmid">27978487</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cruciani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Etna</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Camilli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Giacomini</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Percario</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Severa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sandini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rizzo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Brandi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Balsamo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Polticelli</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Affabris</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pantosti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bagnoli</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Coccia</surname><given-names>EM</given-names></name></person-group>
<year>2017</year>
<article-title><italic>Staphylococcus aureus</italic> Esx factors control human dendritic cell functions conditioning Th1/Th17 response</article-title>. <source>Front Cell Infect Microbiol</source>
<volume>7</volume>:<fpage>330</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2017.00330</pub-id>.<pub-id pub-id-type="pmid">28785545</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uebele</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kleinert</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ticha</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bierbaum</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gotz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bekeredjian-Ding</surname><given-names>I</given-names></name></person-group>
<year>2017</year>
<article-title>Antigen delivery to dendritic cells shapes human CD4<sup>+</sup> and CD8<sup>+</sup> T cell memory responses to <italic>Staphylococcus aureus</italic></article-title>. <source>PLoS Pathog</source>
<volume>13</volume>:<elocation-id>e1006387</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1006387</pub-id>.<pub-id pub-id-type="pmid">28542586</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reyes-Robles</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lubkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Lacy</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2016</year>
<article-title>Exploiting dominant-negative toxins to combat <italic>Staphylococcus aureus</italic> pathogenesis</article-title>. <source>EMBO Rep</source>
<volume>17</volume>:<fpage>780</fpage>. doi:<pub-id pub-id-type="doi">10.15252/embr.201670010</pub-id>.<pub-id pub-id-type="pmid">27139260</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boles</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Thoendel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Horswill</surname><given-names>AR</given-names></name></person-group>
<year>2010</year>
<article-title>Identification of genes involved in polysaccharide-independent <italic>Staphylococcus aureus</italic> biofilm formation</article-title>. <source>PLoS One</source>
<volume>5</volume>:<elocation-id>e10146</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0010146</pub-id>.<pub-id pub-id-type="pmid">20418950</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuMont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Nygaard</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kozhaya</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kreiswirth</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Shopsin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Unutmaz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Voyich</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2011</year>
<article-title>Characterization of a new cytotoxin that contributes to <italic>Staphylococcus aureus</italic> pathogenesis</article-title>. <source>Mol Microbiol</source>
<volume>79</volume>:<fpage>814</fpage>&#x02013;<lpage>825</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07490.x</pub-id>.<pub-id pub-id-type="pmid">21255120</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voyich</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Braughton</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Sturdevant</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Whitney</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Said-Salim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Porcella</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Dorward</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Gardner</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Kreiswirth</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Musser</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name></person-group>
<year>2005</year>
<article-title>Insights into mechanisms used by <italic>Staphylococcus aureus</italic> to avoid destruction by human neutrophils</article-title>. <source>J Immunol</source>
<volume>175</volume>:<fpage>3907</fpage>&#x02013;<lpage>3919</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.175.6.3907</pub-id>.<pub-id pub-id-type="pmid">16148137</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nygaard</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Pallister</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Ruzevich</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Griffith</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vuong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Voyich</surname><given-names>JM</given-names></name></person-group>
<year>2010</year>
<article-title>SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis</article-title>. <source>J Infect Dis</source>
<volume>201</volume>:<fpage>241</fpage>&#x02013;<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1086/649570</pub-id>.<pub-id pub-id-type="pmid">20001858</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Malachowa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hammer</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Nardone</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name></person-group>
<year>2010</year>
<article-title>Identification of a novel <italic>Staphylococcus aureus</italic> two-component leukotoxin using cell surface proteomics</article-title>. <source>PLoS One</source>
<volume>5</volume>:<elocation-id>e11634</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0011634</pub-id>.<pub-id pub-id-type="pmid">20661294</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuMont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Yoong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>McDonald</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Jennings</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Staphylococcus aureus</italic> LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>110</volume>:<fpage>10794</fpage>&#x02013;<lpage>10799</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1305121110</pub-id>.<pub-id pub-id-type="pmid">23754403</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melehani</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>James</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>DuMont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>JA</given-names></name></person-group>
<year>2015</year>
<article-title><italic>Staphylococcus aureus</italic> leukocidin A/B (LukAB) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>:<elocation-id>e1004970</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004970</pub-id>.<pub-id pub-id-type="pmid">26069969</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genestier</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Michallet</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Prevost</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bellot</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chalabreysse</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Peyrol</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thivolet</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Etienne</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lina</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vallette</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Vandenesch</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Genestier</surname><given-names>L</given-names></name></person-group>
<year>2005</year>
<article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils</article-title>. <source>J Clin Invest</source>
<volume>115</volume>:<fpage>3117</fpage>&#x02013;<lpage>3127</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI22684</pub-id>.<pub-id pub-id-type="pmid">16276417</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yarovinsky</surname><given-names>TO</given-names></name>, <name name-style="western"><surname>Monick</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Husmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hunninghake</surname><given-names>GW</given-names></name></person-group>
<year>2008</year>
<article-title>Interferons increase cell resistance to staphylococcal alpha-toxin</article-title>. <source>Infect Immun</source>
<volume>76</volume>:<fpage>571</fpage>&#x02013;<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.01088-07</pub-id>.<pub-id pub-id-type="pmid">18070901</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craven</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gris</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McElvania-Tekippe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ting</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>J</given-names></name></person-group>
<day>14</day>
<month>10</month>
<year>2009</year>
<article-title><italic>Staphylococcus aureus</italic> alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells</article-title>. <source>PLoS One</source> doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0007446</pub-id>.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holzinger</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gieldon</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mysore</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nippe</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Taxman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Broglie</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Marketon</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Austermann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vogl</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Foell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Niemann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Loffler</surname><given-names>B</given-names></name></person-group>
<year>2012</year>
<article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome</article-title>. <source>J Leukoc Biol</source>
<volume>92</volume>:<fpage>1069</fpage>&#x02013;<lpage>1081</lpage>. doi:<pub-id pub-id-type="doi">10.1189/jlb.0112014</pub-id>.<pub-id pub-id-type="pmid">22892107</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenlee-Wacker</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Rigby</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Nauseef</surname><given-names>WM</given-names></name></person-group>
<year>2014</year>
<article-title>Phagocytosis of <italic>Staphylococcus aureus</italic> by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis</article-title>. <source>J Immunol</source>
<volume>192</volume>:<fpage>4709</fpage>&#x02013;<lpage>4717</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1302692</pub-id>.<pub-id pub-id-type="pmid">24729616</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitur</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nieto</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ahn</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wachtel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bueno</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>A</given-names></name></person-group>
<year>2015</year>
<article-title>Toxin-induced necroptosis is a major mechanism of <italic>Staphylococcus aureus</italic> lung damage</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>:<elocation-id>e1004820</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004820</pub-id>.<pub-id pub-id-type="pmid">25880560</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aerts-Toegaert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Heirman</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tuyaerts</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Corthals</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aerts</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Bonehill</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thielemans</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Breckpot</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>CD83 expression on dendritic cells and T cells: correlation with effective immune responses</article-title>. <source>Eur J Immunol</source>
<volume>37</volume>:<fpage>686</fpage>&#x02013;<lpage>695</lpage>. doi:<pub-id pub-id-type="doi">10.1002/eji.200636535</pub-id>.<pub-id pub-id-type="pmid">17301951</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freeman</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Borriello</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hodes</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Reiser</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gribben</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Goldberg</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Hathcock</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Laszlo</surname><given-names>G</given-names></name></person-group>
<year>1993</year>
<article-title>Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production</article-title>. <source>J Exp Med</source>
<volume>178</volume>:<fpage>2185</fpage>&#x02013;<lpage>2192</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.178.6.2185</pub-id>.<pub-id pub-id-type="pmid">7504059</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hathcock</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Laszlo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dickler</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Bradshaw</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Linsley</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hodes</surname><given-names>RJ</given-names></name></person-group>
<year>1993</year>
<article-title>Identification of an alternative CTLA-4 ligand costimulatory for T cell activation</article-title>. <source>Science</source>
<volume>262</volume>:<fpage>905</fpage>&#x02013;<lpage>907</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.7694361</pub-id>.<pub-id pub-id-type="pmid">7694361</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moody</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Ulrichs</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Muhlecker</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Gurcha</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rosat</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Costello</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Besra</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Porcelli</surname><given-names>SA</given-names></name></person-group>
<year>2000</year>
<article-title>CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection</article-title>. <source>Nature</source>
<volume>404</volume>:<fpage>884</fpage>&#x02013;<lpage>888</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35009119</pub-id>.<pub-id pub-id-type="pmid">10786796</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shackelford</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Korman</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Strominger</surname><given-names>JL</given-names></name></person-group>
<year>1982</year>
<article-title>HLA-DR antigens: structure, separation of subpopulations, gene cloning and function</article-title>. <source>Immunol Rev</source>
<volume>66</volume>:<fpage>133</fpage>&#x02013;<lpage>187</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-065X.1982.tb00437.x</pub-id>.<pub-id pub-id-type="pmid">6813244</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uotila</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Aatonen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gahmberg</surname><given-names>CG</given-names></name></person-group>
<year>2013</year>
<article-title>Integrin CD11c/CD18 alpha-chain phosphorylation is functionally important</article-title>. <source>J Biol Chem</source>
<volume>288</volume>:<fpage>33494</fpage>&#x02013;<lpage>33499</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.C113.497446</pub-id>.<pub-id pub-id-type="pmid">24129562</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holtfreter</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kolata</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Broker</surname><given-names>BM</given-names></name></person-group>
<year>2010</year>
<article-title>Towards the immune proteome of <italic>Staphylococcus aureus</italic>&#x02014;the anti-S. aureus antibody response</article-title>. <source>Int J Med Microbiol</source>
<volume>300</volume>:<fpage>176</fpage>&#x02013;<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijmm.2009.10.002</pub-id>.<pub-id pub-id-type="pmid">19889576</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kloppot</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Selle</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kohler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Stentzel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liebscher</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kale</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ohlsen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Broker</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Zipfel</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Kahl</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Ehricht</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hecker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Engelmann</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Microarray-based identification of human antibodies against <italic>Staphylococcus aureus</italic> antigens</article-title>. <source>Proteomics Clin Appl</source>
<volume>9</volume>:<fpage>1003</fpage>&#x02013;<lpage>1011</lpage>. doi:<pub-id pub-id-type="doi">10.1002/prca.201400123</pub-id>.<pub-id pub-id-type="pmid">25676254</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomsen</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Dumont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>James</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Yoong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Saville</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Soper</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Creech</surname><given-names>CB</given-names></name></person-group>
<year>2014</year>
<article-title>Children with invasive <italic>Staphylococcus aureus</italic> disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB</article-title>. <source>Infect Immun</source>
<volume>82</volume>:<fpage>1234</fpage>&#x02013;<lpage>1242</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.01558-13</pub-id>.<pub-id pub-id-type="pmid">24379282</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomsen</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Sapparapu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>James</surname><given-names>DBA</given-names></name>, <name name-style="western"><surname>Cassat</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Nagarsheth</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kose</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Putnam</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Boguslawski</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Creech</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Crowe</surname><given-names>JE</given-names><suffix>Jr.</suffix></name></person-group>
<year>2017</year>
<article-title>Monoclonal antibodies against the <italic>Staphylococcus aureus</italic> bicomponent leukotoxin AB isolated following invasive human infection reveal diverse binding and modes of action</article-title>. <source>J Infect Dis</source>
<volume>215</volume>:<fpage>1124</fpage>&#x02013;<lpage>1131</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jix071</pub-id>.<pub-id pub-id-type="pmid">28186295</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolata</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Kuhbandner</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Link</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Normann</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Vu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Steil</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Weidenmaier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Broker</surname><given-names>BM</given-names></name></person-group>
<year>2015</year>
<article-title>The fall of a dogma? Unexpected high T-cell memory response to <italic>Staphylococcus aureus</italic> in humans</article-title>. <source>J Infect Dis</source>
<volume>212</volume>:<fpage>830</fpage>&#x02013;<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiv128</pub-id>.<pub-id pub-id-type="pmid">25737563</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielinski</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aschenbrenner</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jarrossay</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ronchi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gattorno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Monticelli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name></person-group>
<day>26</day>
<month>4</month>
<year>2012</year>
<article-title>Pathogen-induced human TH17 cells produce IFN-&#x003b3; or IL-10 and are regulated by IL-1&#x003b2;</article-title>. <source>Nature</source> doi:<pub-id pub-id-type="doi">10.1038/nature10957</pub-id>.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Lalor</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Leech</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>O&#x02019;Keeffe</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Mac Aog&#x000e1;in</surname><given-names>M</given-names></name>, <name name-style="western"><surname>O&#x02019;Halloran</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Lacey</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Tavakol</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hearnden</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Fitzgerald-Hughes</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Humphreys</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fennell</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>van Wamel</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Geoghegan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>McLoughlin</surname><given-names>RM</given-names></name></person-group>
<year>2015</year>
<article-title>Memory Th1 Cells are protective in invasive <italic>Staphylococcus aureus</italic> infection</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>:<elocation-id>e1005226</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005226</pub-id>.<pub-id pub-id-type="pmid">26539822</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacey</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Leech</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Lalor</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>McCormack</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Geoghegan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>McLoughlin</surname><given-names>RM</given-names></name></person-group>
<day>17</day>
<month>11</month>
<year>2017</year>
<article-title>The <italic>Staphylococcus aureus</italic> cell wall-anchored protein clumping factor A is an important T cell antigen</article-title>. <source>Infect Immun</source> doi:<pub-id pub-id-type="doi">10.1128/IAI.00549-17</pub-id>.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minegishi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nagasawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tsuchiya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Agematsu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kawamura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ariga</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tsuge</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Karasuyama</surname><given-names>H</given-names></name></person-group>
<year>2009</year>
<article-title>Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome</article-title>. <source>J Exp Med</source>
<volume>206</volume>:<fpage>1291</fpage>&#x02013;<lpage>1301</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20082767</pub-id>.<pub-id pub-id-type="pmid">19487419</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagl</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kacani</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mullauer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lemberger</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Stoiber</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sprinzl</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Schennach</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dierich</surname><given-names>MP</given-names></name></person-group>
<year>2002</year>
<article-title>Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells</article-title>. <source>Clin Diagn Lab Immunol</source>
<volume>9</volume>:<fpage>1165</fpage>&#x02013;<lpage>1168</lpage>.<pub-id pub-id-type="pmid">12414745</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schindler</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gutierrez</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Beineke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rauter</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rohde</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Goldmann</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Medina</surname><given-names>E</given-names></name></person-group>
<year>2012</year>
<article-title>Dendritic cells are central coordinators of the host immune response to <italic>Staphylococcus aureus</italic> bloodstream infection</article-title>. <source>Am J Pathol</source>
<volume>181</volume>:<fpage>1327</fpage>&#x02013;<lpage>1337</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajpath.2012.06.039</pub-id>.<pub-id pub-id-type="pmid">22885107</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Q</given-names></name></person-group>
<year>2014</year>
<article-title>BDCA1-positive dendritic cells (DCs) represent a unique human myeloid DC subset that induces innate and adaptive immune responses to <italic>Staphylococcus aureus</italic> Infection</article-title>. <source>Infect Immun</source>
<volume>82</volume>:<fpage>4466</fpage>&#x02013;<lpage>4476</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.01851-14</pub-id>.<pub-id pub-id-type="pmid">25114114</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Chaili</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Filler</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Solis</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Yeaman</surname><given-names>MR</given-names></name></person-group>
<day>26</day>
<month>1</month>
<year>2017</year>
<article-title>Innate immune memory contributes to host defense against recurrent skin and skin structure infections caused by methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Infect Immun</source> doi:<pub-id pub-id-type="doi">10.1128/IAI.00876-16</pub-id>.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Joosten</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Latz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Natoli</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stunnenberg</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Xavier</surname><given-names>RJ</given-names></name></person-group>
<year>2016</year>
<article-title>Trained immunity: a program of innate immune memory in health and disease</article-title>. <source>Science</source>
<volume>352</volume>:<fpage>aaf1098</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aaf1098</pub-id>.<pub-id pub-id-type="pmid">27102489</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title><italic>Staphylococcus aureus</italic> induces type I IFN signaling in dendritic cells via TLR9</article-title>. <source>J Immunol</source>
<volume>189</volume>:<fpage>4040</fpage>&#x02013;<lpage>4046</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1201055</pub-id>.<pub-id pub-id-type="pmid">22962685</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreiner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kretschmer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Klenk</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Otto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buhring</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Stevanovic</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Beer-Hammer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peschel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Autenrieth</surname><given-names>SE</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Staphylococcus aureus</italic> phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells</article-title>. <source>J Immunol</source>
<volume>190</volume>:<fpage>3417</fpage>&#x02013;<lpage>3426</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1202563</pub-id>.<pub-id pub-id-type="pmid">23460735</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salgado-Pab&#x000f3;n</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schlievert</surname><given-names>PM</given-names></name></person-group>
<year>2014</year>
<article-title>Models matter: the search for an effective <italic>Staphylococcus aureus</italic> vaccine</article-title>. <source>Nat Rev Microbiol</source>
<volume>12</volume>:<fpage>585</fpage>&#x02013;<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3308</pub-id>.<pub-id pub-id-type="pmid">24998740</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prince</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kitur</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>D</given-names></name></person-group>
<day>1</day>
<month>5</month>
<year>2016</year>
<article-title>Humanized mice exhibit increased susceptibility to <italic>Staphylococcus aureus</italic> pneumonia</article-title>. <source>J Infect Dis</source> doi:<pub-id pub-id-type="doi">10.1093/infdis/jiw425</pub-id>.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Biancotti</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Berg</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Gate</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kolar</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Rezai-Zadeh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Beenhouwer</surname><given-names>DO</given-names></name>, <name name-style="western"><surname>Town</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>GY</given-names></name></person-group>
<year>2015</year>
<article-title>Increased susceptibility of humanized NSG mice to Panton-Valentine leukocidin and <italic>Staphylococcus aureus</italic> skin infection</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>:<elocation-id>e1005292</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005292</pub-id>.<pub-id pub-id-type="pmid">26618545</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lilo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nygaard</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Voyich</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2012</year>
<article-title>Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins</article-title>. <source>J Bacteriol</source>
<volume>194</volume>:<fpage>4355</fpage>&#x02013;<lpage>4365</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00706-12</pub-id>.<pub-id pub-id-type="pmid">22685286</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berends</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Dekkers</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Nijland</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kuipers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Soppe</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Rooijakkers</surname><given-names>SH</given-names></name></person-group>
<year>2013</year>
<article-title>Distinct localization of the complement C5b-9 complex on Gram-positive bacteria</article-title>. <source>Cell Microbiol</source>
<volume>15</volume>:<fpage>1955</fpage>&#x02013;<lpage>1968</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cmi.12170</pub-id>.<pub-id pub-id-type="pmid">23869880</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reyes-Robles</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Kozhaya</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lacy</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Unutmaz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2013</year>
<article-title><italic>Staphylococcus aureus</italic> leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection</article-title>. <source>Cell Host Microbe</source>
<volume>14</volume>:<fpage>453</fpage>&#x02013;<lpage>459</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2013.09.005</pub-id>.<pub-id pub-id-type="pmid">24139401</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Perdreau-Remington</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rieg</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mehdi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Perlroth</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bayer</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Phung</surname><given-names>TO</given-names></name>, <name name-style="western"><surname>Spellberg</surname><given-names>B</given-names></name></person-group>
<year>2005</year>
<article-title>Necrotizing fasciitis caused by community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> in Los Angeles</article-title>. <source>N Engl J Med</source>
<volume>352</volume>:<fpage>1445</fpage>&#x02013;<lpage>1453</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa042683</pub-id>.<pub-id pub-id-type="pmid">15814880</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diep</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Phan</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Carleton</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Mongodin</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Sensabaugh</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Perdreau-Remington</surname><given-names>F</given-names></name></person-group>
<year>2006</year>
<article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Lancet</source>
<volume>367</volume>:<fpage>731</fpage>&#x02013;<lpage>739</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id>.<pub-id pub-id-type="pmid">16517273</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ohneck</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Smith</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Narechania</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kolokotronis</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Satola</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Uhlemann</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Sebra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Deikus</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shopsin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Planet</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2014</year>
<article-title>Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element</article-title>. <source>Mol Microbiol</source>
<volume>93</volume>:<fpage>664</fpage>&#x02013;<lpage>681</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.12682</pub-id>.<pub-id pub-id-type="pmid">24962815</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shopsin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Drlica-Wagner</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mathema</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Adhikari</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Kreiswirth</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Novick</surname><given-names>RP</given-names></name></person-group>
<year>2008</year>
<article-title>Prevalence of agr dysfunction among colonizing <italic>Staphylococcus aureus</italic> strains</article-title>. <source>J Infect Dis</source>
<volume>198</volume>:<fpage>1171</fpage>&#x02013;<lpage>1174</lpage>. doi:<pub-id pub-id-type="doi">10.1086/592051</pub-id>.<pub-id pub-id-type="pmid">18752431</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kuroda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yuzawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Oguchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nagai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Iwama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Asano</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Naimi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kuroda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hiramatsu</surname><given-names>K</given-names></name></person-group>
<year>2002</year>
<article-title>Genome and virulence determinants of high virulence community-acquired MRSA</article-title>. <source>Lancet</source>
<volume>359</volume>:<fpage>1819</fpage>&#x02013;<lpage>1827</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(02)08713-5</pub-id>.<pub-id pub-id-type="pmid">12044378</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holden</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Feil</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Lindsay</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Peacock</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Enright</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Atkin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Barron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bason</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bentley</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Chillingworth</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chillingworth</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Churcher</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Corton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cronin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Doggett</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dowd</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Feltwell</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hance</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hauser</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Holroyd</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jagels</surname><given-names>K</given-names></name>, <name name-style="western"><surname>James</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Lennard</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Line</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mayes</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moule</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ormond</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Quail</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Rabbinowitsch</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rutherford</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Simmonds</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barrell</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Spratt</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Parkhill</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>Complete genomes of two clinical <italic>Staphylococcus aureus</italic> strains: evidence for the rapid evolution of virulence and drug resistance</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>:<fpage>9786</fpage>&#x02013;<lpage>9791</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0402521101</pub-id>.<pub-id pub-id-type="pmid">15213324</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuroda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ohta</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Uchiyama</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Baba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yuzawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Oguchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nagai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kanamori</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Matsumaru</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Maruyama</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hosoyama</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mizutani-Ui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Sawano</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kaito</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sekimizu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hirakawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kuhara</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yabuzaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Oshima</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Furuya</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yoshino</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shiba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ogasawara</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hayashi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hiramatsu</surname><given-names>K</given-names></name></person-group>
<year>2001</year>
<article-title>Whole genome sequencing of meticillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Lancet</source>
<volume>357</volume>:<fpage>1225</fpage>&#x02013;<lpage>1240</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(00)04403-2</pub-id>.<pub-id pub-id-type="pmid">11418146</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Narechania</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sebra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Deikus</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Larussa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mathema</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ratner</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Kreiswirth</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Planet</surname><given-names>PJ</given-names></name></person-group>
<day>10</day>
<month>4</month>
<year>2014</year>
<article-title>Genome sequence of bacterial interference strain <italic>Staphylococcus aureus</italic> 502A</article-title>. <source>Genome Announc</source> doi:<pub-id pub-id-type="doi">10.1128/genomeA.00284-14</pub-id>.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gillaspy</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Hickmon</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Smeltzer</surname><given-names>MS</given-names></name></person-group>
<year>1995</year>
<article-title>Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis</article-title>. <source>Infect Immun</source>
<volume>63</volume>:<fpage>3373</fpage>&#x02013;<lpage>3380</lpage>.<pub-id pub-id-type="pmid">7642265</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wormann</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Reichmann</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Malone</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Horswill</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Grundling</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Proteolytic cleavage inactivates the <italic>Staphylococcus aureus</italic> lipoteichoic acid synthase</article-title>. <source>J Bacteriol</source>
<volume>193</volume>:<fpage>5279</fpage>&#x02013;<lpage>5291</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00369-11</pub-id>.<pub-id pub-id-type="pmid">21784926</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blake</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Baral</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Voisin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lubkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pinho-Ribeiro</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Roberson</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Otto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Woolf</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>IM</given-names></name></person-group>
<year>2018</year>
<article-title><italic>Staphylococcus aureus</italic> produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314</article-title>. <source>Nat Commun</source>
<volume>9</volume>:<fpage>37</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-017-02448-6</pub-id>.<pub-id pub-id-type="pmid">29295977</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name></person-group>
<year>2015</year>
<article-title>Counter inhibition between leukotoxins attenuates <italic>Staphylococcus aureus</italic> virulence</article-title>. <source>Nat Commun</source>
<volume>6</volume>:<fpage>8125</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms9125</pub-id>.<pub-id pub-id-type="pmid">26330208</pub-id></mixed-citation></ref></ref-list></back></article>